UK Companies House feature
REHAB-LINK LIMITED
Cash
£101K
-0.1% vs 2023
Net assets
£5M
+20.8% vs 2023
Employees
44
-8.3% vs 2023
Profit before tax
£1M
-10.6% vs 2023
Profile
- Company number
- 10339477
- Status
- Active
- Incorporation
- 2016-08-22
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2024-12-31
| Metric | Trend | 2018-06-30 | 2019-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | £10,836,125 | — | £13,774,552 | £15,238,020 | £15,315,477 | |
| Operating profit | — | — | — | — | £1,012,530 | £1,230,499 | £1,118,956 | |
| Profit before tax | — | — | £455,027 | £781,445 | £1,011,639 | £1,229,868 | £1,099,022 | |
| Net profit | — | — | £376,172 | £632,692 | £896,377 | £985,797 | £814,248 | |
| Cash | — | — | £1,886 | £75 | £1,469 | £101,429 | £101,304 | |
| Total assets less current liabilities | — | — | — | £2,081,907 | £2,978,284 | £3,964,081 | £4,739,231 | |
| Net assets | — | — | £1,409,215 | £2,041,907 | £2,938,284 | £3,924,081 | £4,738,329 | |
| Equity | £409,528 | £1,032,044 | £1,409,215 | £2,041,907 | £2,938,284 | £3,924,081 | £4,738,329 | |
| Average employees | — | — | 28 | 35 | 45 | 48 | 44 | |
| Wages | — | — | — | — | £969,932 | £1,065,818 | £1,061,903 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Price Bailey LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After considering the company's forecast for the next 12 months, the directors have a reasonable expectation that the company has adequate cash and resources to meet all requirements to continue in operational existence for the foreseeable future. The directors have also received confirmation that the parent company will continue to provide support where necessary.”
Significant events
- “During the year the Group and Company refinanced from Barclays Bank Plc to RBS Invoice Discounting Limited, which increased the credit facility available.”
- “The industry in which the group operates has been affected by uncertainty caused by the Chancellors announcement in the 2015 Autumn Statement that they will abolish general damages for 'minor' soft tissue claims which was proposed to include whiplash injuries. The reforms have been implemented in May 2021 and present both a risk and an opportunity to future volumes.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BRUNJES, Henry Otto, Dr | Director | 2017-03-06 | Oct 1954 | British |
| GRAY, Barry | Director | 2026-04-09 | Jun 1975 | British |
| SAMPSON, Gavin James | Director | 2026-04-09 | Nov 1986 | British |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GOODALL, Robert Colin, Dr | Director | 2017-06-19 | 2026-04-09 |
| STIRRUP, Mark Christopher | Director | 2016-08-22 | 2017-04-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kuro Health Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-08-22 | Active |
Filing timeline
Last 20 of 40 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-09 | AP01 | officers | appoint person director company with name date |
| 2026-04-09 | AP01 | officers | appoint person director company with name date |
| 2026-04-09 | TM01 | officers | termination director company with name termination date |
| 2026-03-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-08-04 | AA | accounts | accounts with accounts type full |
| 2025-03-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-19 | AA | accounts | accounts with accounts type full |
| 2024-11-27 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-11-25 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-09-27 | AA01 | accounts | change account reference date company previous shortened |
| 2024-03-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-29 | AA | accounts | accounts with accounts type full |
| 2023-03-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-30 | AA | accounts | accounts with accounts type full |
| 2022-03-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-01 | RESOLUTIONS | resolution | resolution |
| 2021-09-30 | AA | accounts | accounts with accounts type full |
| 2021-03-24 | AA01 | accounts | change account reference date company previous extended |
| 2021-03-05 | CS01 | confirmation-statement | confirmation statement with updates |
| 2021-03-05 | PSC05 | persons-with-significant-control | change to a person with significant control |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
2.98
SAFE
Altman Z″
- Working capital / Total assets 0.309 × 6.56 = +2.02
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.073 × 6.72 = +0.49
- Book equity / Total liabilities 0.447 × 1.05 = +0.47
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory